latest newsAppendix 3B BioDiem supports WHO's Global Pandemic Influenza Action Plan Appendix 4C Quarterly Report Change of Director's Interest Notice Half Year Financial Reports Commencement of Phase I clinical trials for LAIV Board Changes Appendix 4C Quarterly Report Phase II results for H5 vaccine confirms safety & immunogenicity BioDiem receives 6th Milestone of US$1m for flu vaccine Results of AGM 26 November 2008 CEO's Presentation to AGM Chairman's Address to Shareholders Appendix 4C Quarterly Report Notice of Annual General Meeting & Proxy Form 2008 Annual Report to Shareholders 2008 | Investor InformationASX Announcements Financial Results
| ASX Link
|